Deteriorated biomechanical properties of human hypertrophied septum in response to cardiomyocyte enlargement, overexpressed collagen, and disarrayed microstructures.

IF 4.8 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-06-02 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1620594
Katherine M Copeland, Houjia Chen, Uday Chintapula, Milad Almasian, Duc Khang Chung, Alan M Taylor, Yichen Ding, Gaurav Sharma, Michael E Jessen, Yi Hong, Kytai T Nguyen, Matthias Peltz, Pietro Bajona, Jun Liao
{"title":"Deteriorated biomechanical properties of human hypertrophied septum in response to cardiomyocyte enlargement, overexpressed collagen, and disarrayed microstructures.","authors":"Katherine M Copeland, Houjia Chen, Uday Chintapula, Milad Almasian, Duc Khang Chung, Alan M Taylor, Yichen Ding, Gaurav Sharma, Michael E Jessen, Yi Hong, Kytai T Nguyen, Matthias Peltz, Pietro Bajona, Jun Liao","doi":"10.3389/fbioe.2025.1620594","DOIUrl":null,"url":null,"abstract":"<p><p>Hypertrophic cardiomyopathy (HCM) is often caused by genetic mutations, resulting in abnormal thickening of ventricular muscle, particularly the septum, and causing left ventricular outflow tract (LVOT) obstruction and inferior cardiac performance. The cell and microstructural abnormalities are believed to be the cause of the altered tissue mechanical properties and inferior performance. However, there is a lack of detailed biomechanical assessments of human hypertrophied septum and a lack of understanding of the structural-mechanical relationship between altered biomechanical properties and cellular hypertrophy, fibrotic overexpression, and microstructural disruptions. In this study, we performed thorough biomechanical and microstructural characterizations on the human hypertrophied septum and compared this with healthy septum. We found that the hypertrophied human septum was stiffer at the initial phase of tissue loading, but less nonlinear, less stiff in the linear region, and much weaker in mechanical strength when compared to the healthy human septum. The fibrosis-induced initial stiffening in the hypertrophied septum paradoxically coexists with compromised mechanical strength and integrity under physiological demands, correlating with the clinical observations of diastolic dysfunction and susceptibility to myocardial damage in HCM patients despite ventricular wall thickening. We also discovered that the human hypertrophied septum had significantly larger stress relaxation and slightly larger creep when compared to healthy septum. Moreover, the abnormal, disorganized cell-collagen microstructures in the hypertrophied septum make short-term stress release more difficult and require longer relaxation times to reach equilibrium. Biaxial testing performed at the initial phase of tissue loading showed that both the healthy septum and hypertrophied septum had nonlinear anisotropic stress-strain behavior and confirmed that, in the longitudinal direction, the hypertrophied septum was stiffer than the healthy septum. Our microstructural quantifications via histology and light-sheet microscopy revealed that (i) the heterogeneous cardiomyocyte enlargement and disarray, combined with disorganized collagen overexpression, create a mechanically inefficient tissue architecture in the hypertrophied septum, and (ii) the observed cell-collagen microstructural disruptions provide mechanistic explanations for the deteriorated biomechanical properties. Our viscoelastic mechanical data and microstructural characterizations build a strong foundation to understand the altered tissue behavior of the hypertrophied septum, the degree of deviation from the normal septum, and the underlying structural mechanisms.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1620594"},"PeriodicalIF":4.8000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171370/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1620594","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertrophic cardiomyopathy (HCM) is often caused by genetic mutations, resulting in abnormal thickening of ventricular muscle, particularly the septum, and causing left ventricular outflow tract (LVOT) obstruction and inferior cardiac performance. The cell and microstructural abnormalities are believed to be the cause of the altered tissue mechanical properties and inferior performance. However, there is a lack of detailed biomechanical assessments of human hypertrophied septum and a lack of understanding of the structural-mechanical relationship between altered biomechanical properties and cellular hypertrophy, fibrotic overexpression, and microstructural disruptions. In this study, we performed thorough biomechanical and microstructural characterizations on the human hypertrophied septum and compared this with healthy septum. We found that the hypertrophied human septum was stiffer at the initial phase of tissue loading, but less nonlinear, less stiff in the linear region, and much weaker in mechanical strength when compared to the healthy human septum. The fibrosis-induced initial stiffening in the hypertrophied septum paradoxically coexists with compromised mechanical strength and integrity under physiological demands, correlating with the clinical observations of diastolic dysfunction and susceptibility to myocardial damage in HCM patients despite ventricular wall thickening. We also discovered that the human hypertrophied septum had significantly larger stress relaxation and slightly larger creep when compared to healthy septum. Moreover, the abnormal, disorganized cell-collagen microstructures in the hypertrophied septum make short-term stress release more difficult and require longer relaxation times to reach equilibrium. Biaxial testing performed at the initial phase of tissue loading showed that both the healthy septum and hypertrophied septum had nonlinear anisotropic stress-strain behavior and confirmed that, in the longitudinal direction, the hypertrophied septum was stiffer than the healthy septum. Our microstructural quantifications via histology and light-sheet microscopy revealed that (i) the heterogeneous cardiomyocyte enlargement and disarray, combined with disorganized collagen overexpression, create a mechanically inefficient tissue architecture in the hypertrophied septum, and (ii) the observed cell-collagen microstructural disruptions provide mechanistic explanations for the deteriorated biomechanical properties. Our viscoelastic mechanical data and microstructural characterizations build a strong foundation to understand the altered tissue behavior of the hypertrophied septum, the degree of deviation from the normal septum, and the underlying structural mechanisms.

心肌细胞增大、胶原蛋白过度表达和微结构紊乱导致的人中隔肥大生物力学性能恶化。
肥厚性心肌病(HCM)常由基因突变引起,导致室间隔肌异常增厚,引起左心室流出道(LVOT)梗阻和心脏功能低下。细胞和显微结构的异常被认为是导致组织力学性能改变和性能下降的原因。然而,目前缺乏详细的生物力学评估,也缺乏对生物力学特性改变与细胞肥大、纤维化过表达和微结构破坏之间的结构-力学关系的理解。在这项研究中,我们对人类肥大的中隔进行了全面的生物力学和微观结构表征,并将其与健康的中隔进行了比较。我们发现,与健康的人隔膜相比,肥大的人隔膜在组织加载的初始阶段更硬,但非线性更小,线性区域更少僵硬,机械强度更弱。在肥厚的室间隔中,纤维化诱导的初始硬化与生理需求下的机械强度和完整性受损矛盾地共存,这与HCM患者尽管心室壁增厚,但舒张功能障碍和心肌损伤易感性的临床观察有关。我们还发现,与健康的鼻中隔相比,人类肥大的鼻中隔有明显更大的应力松弛和略大的蠕变。此外,肥大的隔膜中异常、紊乱的细胞-胶原微结构使短期应激释放更加困难,需要更长的松弛时间才能达到平衡。在组织加载初始阶段进行的双轴试验表明,健康隔膜和肥大隔膜均具有非线性各向异性应力-应变行为,并证实在纵向上,肥大隔膜比健康隔膜更硬。我们通过组织学和薄层显微镜进行的显微结构定量分析显示:(i)异质心肌细胞的扩大和紊乱,加上胶原蛋白的无序过度表达,在肥厚的隔膜中造成了机械效率低下的组织结构,(ii)观察到的细胞-胶原蛋白微结构破坏为恶化的生物力学特性提供了机制解释。我们的粘弹性力学数据和微观结构特征为理解肥大的中隔改变的组织行为、偏离正常中隔的程度以及潜在的结构机制奠定了坚实的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信